These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2437220)

  • 1. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
    Black RE; Levine MM; Clements ML; Losonsky G; Herrington D; Berman S; Formal SB
    J Infect Dis; 1987 Jun; 155(6):1260-5. PubMed ID: 2437220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
    Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
    Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
    Van de Verg L; Herrington DA; Murphy JR; Wasserman SS; Formal SB; Levine MM
    Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
    Herrington DA; Van de Verg L; Formal SB; Hale TL; Tall BD; Cryz SJ; Tramont EC; Levine MM
    Vaccine; 1990 Aug; 8(4):353-7. PubMed ID: 2204243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
    J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.
    Formal SB; Baron LS; Kopecko DJ; Washington O; Powell C; Life CA
    Infect Immun; 1981 Dec; 34(3):746-50. PubMed ID: 6174449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
    Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
    J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.
    Cohen D; Ashkenazi S; Green MS; Gdalevich M; Robin G; Slepon R; Yavzori M; Orr N; Block C; Ashkenazi I; Shemer J; Taylor DN; Hale TL; Sadoff JC; Pavliakova D; Schneerson R; Robbins JB
    Lancet; 1997 Jan; 349(9046):155-9. PubMed ID: 9111538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell wall structures which may be important for successful immunization with Salmonella-Shigella hybrid vaccines.
    Schultz CL; Kaufman B; Hamilton D; Hartman A; Ruiz M; Powell C; Berman S
    Vaccine; 1990 Apr; 8(2):115-20. PubMed ID: 2159678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G.
    Clarkson KA; Frenck RW; Dickey M; Suvarnapunya AE; Chandrasekaran L; Weerts HP; Heaney CD; McNeal M; Detizio K; Parker S; Hoeper A; Bourgeois AL; Porter CK; Venkatesan MM; Kaminski RW
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968012
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.
    Keren DF; Collins HH; Baron LS; Kopecko DJ; Formal SB
    Infect Immun; 1982 Jul; 37(1):387-9. PubMed ID: 7049953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
    Xu DQ; Cisar JO; Ambulos N; Burr DH; Kopecko DJ
    Infect Immun; 2002 Aug; 70(8):4414-23. PubMed ID: 12117952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults.
    Pitisuttithum P; Islam D; Chamnanchanunt S; Ruamsap N; Khantapura P; Kaewkungwal J; Kittitrakul C; Luvira V; Dhitavat J; Venkatesan MM; Mason CJ; Bodhidatta L
    Clin Vaccine Immunol; 2016 Jul; 23(7):564-75. PubMed ID: 27146000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    Venkatesan MM; Ballou C; Barnoy S; McNeal M; El-Khorazaty J; Frenck R; Baqar S
    PLoS One; 2021; 16(11):e0259361. PubMed ID: 34793505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain.
    Hartman AB; Ruiz MM; Schultz CL
    J Clin Microbiol; 1991 Jan; 29(1):27-32. PubMed ID: 1993762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.